Table 1 In vitro antifungal susceptibility pattern of pathogenic Candida clinical isolates (from bloodstream) to the most commonly used drugs belonging to the four different classes of antifungals
From: Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris
Antifungal drugs | Species (n) | |||||
|---|---|---|---|---|---|---|
MIC50 range (μg/ml) | ||||||
Clinical isolates_ Cha (34) | C. albicans (20) | C. tropicalis (34) | C. glabrata (9) | C. lusitaniae (2) | C. parapsilosis (23) | |
Fluconazole | 16–64 | 1 | 1 | 0.5–1 | 0.5–1 | ≤1 |
Amphotericin B | 4–16 | 0.25 | 0.25 | 0.25–0.5 | 0.12–0.25 | 0.25–0.5 |
Flucytosine | 0.25 | ≤1 | ≤1 | ≤1 | ≤1 | ≤1 |
Caspofungin | 0.25 | 0.25 | 0.25 | 0.12 | 0.12 | 0.25–1 |